Real Chemist

• chronic lymphocytic leukaemia (CLL). Venclyxto may be given to you in combination with other medicines or alone.
• acute myeloid leukaemia (AML). Venclyxto will be given in combination with other medicines.

• High effectiveness
• Safe to use
• High solubility

Other Details:

• Dose: 100 mg

Pazopanib is used to treat kidney cancer. It may also be used to treat certain other types of cancer (soft tissue sarcoma). Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by decreasing the blood supply to the cancer tumor to slow tumor growth.

This medication should not be used in children, especially younger than 2 years of age, because of the risk of serious side effects.

Xbira 250 mg Tablet is an anticancer drug used in men along with another drug called prednisone for the treatment of prostate cancer that has spread to other parts of the body. It is generally used in patients who are not responding to other treatment options.

Product description:

• It contains Drug / Molecules called “Erlotinib”
• It belongs to Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors
• The medication works by interfering with the protein epidermal growth factor to prevent it from activating enzymes, cancer cells require these to multiply, grow and spread

• Erlonat is used for the treatment of advance or metastatic Non-Small Cell Lung cancer

Product description:

• Pacli taxel is used to treat various types of cancer
• It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth

• Bone marrow depression, hypersensitivity reactions, myalgia, chest pain, bradycardia
• A stocking-glove sensory neuropathy, mucositis, nausea, vomiting, diarrhoea, alopecia
• Tachycardia, rash, hypotension, arthralgia

Product description:

Product description:

• This medication stimulates the production of white blood cells
• It is prescribed for neutropenia
• It is also used to decrease the incidence of infection in cancer patients who are under chemotherapy treatment or a bone marrow transplant

• Musculoskeletal Pain, Bone Pain, Hypersensitivity Reactions, Spleen Enlargement, Hepatomegaly, Thrombocytopenia, Anaemia, Epistaxis, Headache, Nausea, Vomiting, Diarrhoea, Urinary Abnormalities (Dysuria, Proteinuria, Haematuria), Osteoporosis

Product description:

• Balanced composition
• No side effect
• Long shelf life

Resof L - Sofosbuvir & Ledipasvir

Specifications :-

Brand Name : Resof L
Content : Sofosbuvir & Ledipasvir
Strength : Sofosbuvir 400mg & Ledipasvir 90 mg
Packing : Pack of 28 Tablets
Uses : Treating Chronic Hepatitis C Hirus (HCV) Infection In Certain Patients...

Note: - Resof L Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.

Product Description
The tablets contain sorafenib, which is a small molecular inhibitor of several tyrosine protein kinases. Holding a highly reputed and trusted market standing, we are engaged in offering Sorafenib Tablets. These tablets are used for the treatment of primary kidney cancer and advanced primary liver cancer. We procure these tablets from the reliable and certified vendors of the market. We offer these Sorafenib Tablets at cost effective prices to clients.
Features:

• Taken orally daily once
• Block cell proliferation
• Safe to consume

STIVARGA® (regorafenib) is a prescription medicine used to treat people with:

• colon or rectal cancer that has spread to other parts of the body and for which they have received previous treatment with certain chemotherapy medicines
• a rare stomach, bowel, or esophagus cancer called GIST (gastrointestinal stromal tumor) that cannot be treated with surgery or that has spread to other parts of the body and for which they have received previous treatment with certain medicines

STIVARGA has not been used to treat children less than 18 years of age.

STIVARGA can cause liver problems, which can be serious and sometimes lead to death. Your healthcare provider will do blood tests to check your liver function before you start taking STIVARGA and during your treatment with STIVARGA to check for liver problems. Tell your healthcare provider right away if you experience yellowing of your skin or the white part of your eyes, nausea, vomiting, dark urine, or change in your sleep pattern.

Before taking STIVARGA, tell your healthcare provider if you:

• have liver problems
• have bleeding problems
• have high blood pressure
• have heart problems or chest pain
• plan to have surgery
• have any other medical conditions
• are pregnant or plan to become pregnant. STIVARGA can harm your unborn baby. Females and males should use effective birth control during treatment with STIVARGA and for 2 months after their last dose of STIVARGA. Tell your healthcare provider right away if you or your partner becomes pregnant either while taking STIVARGA or within 2 months after your last dose of STIVARGA
• are breast-feeding or plan to breast-feed. It is not known if STIVARGA passes into your breast milk. You and your healthcare provider should decide if you will take STIVARGA or breast-feed

Tell your healthcare provider about all the prescription and nonprescription medicines, vitamins, and herbal supplements you take. Avoid drinking grapefruit juice and taking St. John's wort while taking STIVARGA.

STIVARGA may cause serious side effects, including:

• severe bleeding. STIVARGA can cause bleeding, which can be serious and sometimes lead to death. Tell your doctor if you have any signs of bleeding while taking STIVARGA, including: vomiting blood or if your vomit looks like coffee grounds, pink or brown urine, red or black (looks like tar) stools, coughing up blood or blood clots, menstrual bleeding that is heavier than normal, unusual vaginal bleeding, nosebleeds that happen often
• a skin problem called hand-foot skin reaction and severe skin rash. Hand-foot skin reaction causes redness, pain, blisters, bleeding, or swelling on the palms of your hands and soles of your feet (which may start as tingling). If you get this side effect or a severe skin rash, your healthcare provider may stop your treatment for some time
• high blood pressure. Your blood pressure should be checked regularly and any high blood pressure should be treated while you are receiving STIVARGA. Tell your healthcare provider if you have severe headaches, light-headedness, or changes in your vision
• decreased blood flow to the heart and heart attack. Get emergency help if you have chest pain, have shortness of breath, feel dizzy, or feel like passing out
• a condition called reversible posterior leukoencephalopathy syndrome (RPLS). Call your healthcare provider right away if you get severe headaches, seizure, confusion, change in vision, or problems thinking.